 Salarius Pharmaceuticals, Inc. NASDAQ:SLRX Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Daniel Kontoh-Boateng - Investor Relations David Arthur - Chief Executive Officer Mark Rosenblum - Chief Financial Officer Nadeem Mirza - Senior Vice President, Clinical Development Daniela Santiesteban - Director, Corporate Development Conference Call Participants Ahu Demir - Ladenburg Hunter Diamond - Diamond Equity Operator Good day, and thank you for standing by. Welcome to the First Quarter 2022 Salarius Pharmaceuticals Earnings Conference Call and Webcast. 